Printer Friendly

Browse Psoriasis topic

 

Articles

1-300 out of 500 article(s) nextnext page
Title Author Type Date Words
Over 1,000 Patients Join Largest Independent U.S. Psoriasis Registry. Mar 28, 2016 648
Delivery of reducing blood clotting, beta-blockers, anti-psoriasis, antibacterial agents for systemic use, baby products, special nutritional products, solutions for perfusion, insulin products for pa. Mar 22, 2016 217
Lilly's Taltz (ixekizumab) Receives U.S. FDA Approval for the Treatment of Moderate-to-Severe Plaque Psoriasis. Mar 22, 2016 2489
Denmark : LEO Pharma Recieves Scientific Approval of Enstilar for the Treatment of Psoriasis in EU. Mar 22, 2016 302
LEO Pharma Receives Scientific Approval of Enstilar for the Treatment of Psoriasis in EU. Mar 21, 2016 1170
LEO Pharma Receives Scientific Approval of Enstilar for the Treatment of Psoriasis in EU. Mar 21, 2016 1177
Treato Finds Patients Demand Celebrities Be Ambassadors for Their Health Conditions. Mar 10, 2016 918
FDA Accepts Amgen's Supplemental Biologics License Application For The Expanded Use Of Enbrel (Etanercept) To Treat Pediatric Patients With Chronic Severe Plaque Psoriasis. Mar 10, 2016 2975
OWC Pharmaceutical Research Corp Completes Formulation of Cannabinoid-Infused Topical Cream. Mar 9, 2016 1080
United States : AbbVie and Boehringer Ingelheim announce global collaboration on promising immunology compounds. Mar 8, 2016 386
Germany : AbbVie and Boehringer Ingelheim announce global collaboration on promising immunology compounds. Mar 8, 2016 386
AbbVie and Boehringer Ingelheim announce global collaboration on promising immunology compounds. Mar 7, 2016 2074
Ixekizumab Demonstrates High Levels of Skin Clearance among Patients with Moderate-to-Severe Plaque Psoriasis Who Did Not Respond to Treatment with Etanercept. Mar 7, 2016 1313
New Novartis data show Cosentyx demonstrated sustained superiority in skin clearance (PASI 90) versus Stelara at Week 52. Mar 5, 2016 3303
Ixekizumab Demonstrates Rapid, Clinically Meaningful Improvements as Early as One Week among Patients with Moderate-to-Severe Plaque Psoriasis. Mar 4, 2016 1372
Germany : Merck Initiates Phase III Study of MSB11022, a Proposed Biosimilar of Adalimumab, in Chronic Plaque Psoriasis. Mar 4, 2016 180
Can-Fite to Present Psoriasis Data at American Academy of Dermatology's 74th Annual Meeting in Washington D.C. on March 7, 2016. Mar 3, 2016 903
Global Psoriasis Partnering 2010 to 2016. Mar 3, 2016 721
Merck KGaA, Darmstadt, Germany Initiates Phase III Study of MSB11022, a Proposed Biosimilar of Adalimumab, in Chronic Plaque Psoriasis. Mar 2, 2016 870
AbbVie Announces New Dermatology Research from More Than 35 Presentations on HUMIRA (Adalimumab), Long-Term and Real-World Data at the American Academy of Dermatology 2016 Annual Meeting. Mar 2, 2016 2118
Rock Creek Pharmaceuticals Announces the Addition of Distinguished Dermatologist as a Scientific Advisor. Mar 1, 2016 1164
Rock Creek Pharmaceuticals Announces the Addition of Distinguished Dermatologist as a Scientific Advisor. Mar 1, 2016 1205
Dubai experts urge early treatment of psoriasis. Disease/Disorder overview Feb 27, 2016 403
Lilly Receives Positive CHMP Opinion for Ixekizumab for the Treatment of Moderate-to-Severe Plaque Psoriasis. Feb 26, 2016 1403
PsoriFix LLC Has Manufactured a New Psoriasis Treatment Cream. Feb 25, 2016 233
New App Offers First Ever Chat-based Nutrition Advice for People With Psoriasis. Feb 18, 2016 582
India,United States : US FDA cleared psoriasis drug of arm of DR REDDY. Feb 9, 2016 207
World's First Psoriatic Disease Patient Navigation Center Now Open. Feb 1, 2016 656
Valeant Announces FDA Acceptance of BLA Submission for Brodalumab in Moderate-to-Severe Plaque Psoriasis. Jan 25, 2016 706
Diplomat Announces COSENTYX Availability for the Treatment of Two New Indications. Jan 20, 2016 809
Can-Fite Announces 2016 Clinical Milestones for its Pipeline of Drugs in Six Indications. Jan 11, 2016 1588
Recurrent lumbosacral herpes simplex virus infection. Vassantachart, Janna M.; Menter, Alan Clinical report Jan 1, 2016 1212
Global Psoriatic Arthritis Market 2015-2019. Dec 22, 2015 717
Europe Psoriasis Market Highlights - Analysis & Opportunities 2015-2020. Dec 21, 2015 439
Europe Psoriasis Market Highlights - Analysis & Opportunities 2015-2020. Dec 21, 2015 479
Book drinking water development project management services psoriasis (acting director not included). Dec 15, 2015 132
Germany,Switzerland : Sandoz advances its biosimilars program with European Medicines Agency (EMA) acceptance of regulatory submission for biosimilar etanercept. Dec 9, 2015 368
Cipher Receives Health Canada Approval of (Pr)Beteflam[TM]. Dec 7, 2015 1368
Biologic Brand Switching Is Becoming More Prevalent As More Treatment Options Are Introduced For Rheumatoid Arthritis And Psoriatic Arthritis. Dec 3, 2015 502
EpiCast Report: Psoriasis - Epidemiology Forecast to 2024. Dec 3, 2015 643
Healer passes his knowledge on to youth. Meili, Dianne Dec 1, 2015 521
Epidemiology of Psoriasis Market Forecast to 2024 in New Report. Report Nov 24, 2015 704
Epidemiology of Psoriasis Market Forecast to 2024 in New Report. Report Nov 24, 2015 708
Charity Launches RCN-Accredited Psoriasis Training for Primary Care Nurses. Nov 9, 2015 491
UCB Presents Latest Research from Immunology Portfolio at American College of Rheumatology Annual Meeting. Nov 6, 2015 4529
Une maladie chronique peu connue. Oct 31, 2015 472
Psoriasis Day boost to net more support. Oct 29, 2015 108
Over 3 percent of Pakistan's population suffering from Psoriasis: Expert. Oct 28, 2015 244
United States : Leo Pharma's Enstilar Foam receives nod from FDA. Oct 23, 2015 166
National Psoriasis Foundation held Skin of Color Congressional Briefing. Oct 22, 2015 581
Denmark : LEO Pharma announces U.S. approval of Enstilar Foam for plaque psoriasis. Oct 20, 2015 267
LEO Pharma Inc. Announces FDA Approval of Enstilar(Calcipotriene and Betamethasone Dipropionate) Foam, 0.005%/0.064% for Plaque Psoriasis. Oct 19, 2015 1230
Rock Creek Pharmaceuticals Announces Successful Completion of Phase I Clinical Trial to Evaluate Oral Formulations of its Lead Compound, Plans to Conduct Proof-of-Concept Trial in Subjects with Mild to Moderate Psoriasis. Oct 15, 2015 1155
Rock Creek Pharmaceuticals Announces Successful Completion of Phase I Clinical Trial to Evaluate Oral Formulations of its Lead Compound, Plans to Conduct Proof-of-Concept Trial in Subjects with Mild to Moderate Psoriasis. Oct 15, 2015 1196
Global Psoriasis Partnering 2010-2015 - Reportlinker Review. Oct 14, 2015 868
Switzerland : Novartis presents new data showing that the majority of patients are able to maintain clear or almost clear skin with Cosentyx across 3 years. Oct 10, 2015 531
Boehringer Ingelheim's investigational biologic cleared skin better, faster and for longer than ustekinumab in phase II psoriasis study. Oct 8, 2015 1178
Germany : Boehringer Ingelheim s investigational biologic cleared skin better, faster and for longer than ustekinumab in phase II psoriasis study. Oct 8, 2015 449
Lilly to Showcase Data for Investigational Psoriasis Treatment at 24th European Academy of Dermatology and Venereology Congress. Oct 6, 2015 1145
AbbVie Demonstrates Leadership in Dermatology with 26 Abstracts at the European Academy of Dermatology and Venereology Congress. Oct 5, 2015 1507
AbbVie Demonstrates Leadership in Dermatology with 26 Abstracts at the European Academy of Dermatology and Venereology Congress. Oct 5, 2015 1543
Psoriasis is independent risk factor for depression. Karon, Amy Oct 1, 2015 289
Psoriasis tied to more distress, worry, irritability. Franki, Lucas Oct 1, 2015 180
80,000 may miss out on psoriasis treatment. Sep 30, 2015 211
Can-Fite to Present CF101 Psoriasis Data at Late Breaking Session of the EADV Congress in Copenhagen on October 10, 2015. Sep 29, 2015 944
NuMedii, Inc. Announces Research Collaboration with Allergan To Explore New Treatments For Psoriasis. Sep 29, 2015 491
New "IL-17A in Psoriasis" Resource Launches on epgonline.org. Sep 26, 2015 424
Global Market for Prescription Dermatological Drugs 2015 - Anti-acne, Anti-aging, Dermatitis, Hair Loss, Psoriasis, Skin Cancer, Melasma and Seborrhea Treatments. Sep 22, 2015 666
Global Market for Prescription Dermatological Drugs 2015 - Anti-acne, Anti-aging, Dermatitis, Hair Loss, Psoriasis, Skin Cancer, Melasma and Seborrhea Treatments. Sep 22, 2015 706
Actress and Best-Selling Author La La Anthony Reveals Journey with Psoriasis - A Chronic, Autoimmune Disease that Threatened to Keep Her Out of the Spotlight. Sep 22, 2015 927
Survey of American Dermatologists and Payers Finds Abbvie's Humira is the Clear Leader in Psoriasis Treatment and that the Availability of Biosimilars and an Increasing Number of IL-17 Inhibitors Will Shape Treatment and Reimbursement Decisions in Coming Years. Sep 21, 2015 798
Learn to be happy in your skin; Most skin diseases aren't life-threatening, but they can be life-altering. LISA SALMON reports on the new website hoping to improve psychological support for around eight million Brits who are affected. Website overview Sep 16, 2015 1153
Learn to be happy in your skin; Most skin diseases aren't life-threatening, but they can be life-altering. LISA SALMON reports on the new website hoping to improve psychological support for around eight million Brits who are affected. Website overview Sep 16, 2015 1148
Learn to be happy in your skin; Most skin diseases aren't life-threatening, but they can be life-altering. LISA SALMON reports on the new website hoping to improve psychological support for around eight million Brits who are affected. Website overview Sep 15, 2015 1163
Learn to be happy in your skin; Most skin diseases aren't life-threatening, but they can be life-altering. LISA SALMON reports on the new website hoping to improve psychological support for around eight million Brits who are affected. Website overview Sep 15, 2015 1175
Learn to be happy in your skin; Most skin diseases aren't life-threatening, but they can be life-altering. LISA SALMON reports on the new website hoping to improve psychological support for around eight million Brits who are affected. Website overview Sep 15, 2015 2275
Janssen's STELARA (Ustekinumab) Available in the UK for the Treatment of Adolescents With Moderate-to-Severe Psoriasis. Sep 13, 2015 2454
PAIN THAT'S MORE THAN SKIN DEEP; The emotional effects of psoriasis and other conditions can be devastating - but help is at hand. Sep 11, 2015 589
UAE one of earliest to have psoriasis medication. Sep 10, 2015 394
KICK PSORIASIS ITCH THE ALL NATURAL "WHEY". Sep 8, 2015 775
Valeant And AstraZeneca To Partner On Brodalumab. Sep 1, 2015 1014
Research suggests benefits of Meriva on psoriasis management. Clinical report Sep 1, 2015 217
A SHOCK IN STORE; Mum with psoriasis is humiliated online by staff after shopping trip. Aug 25, 2015 363
A SHOCK IN STORE; Mum with psoriasis is humiliated online by staff after shopping trip. Aug 25, 2015 365
TGA Approves First mAb Biosimilar. Aug 19, 2015 1540
British Journal of Dermatology publishes International Psoriasis Council psoriasis research priorities. Aug 6, 2015 651
British Journal of Dermatology publishes International Psoriasis Council psoriasis research priorities. Aug 6, 2015 691
LEO Pharma Supports the FDA's Selection of Psoriasis as a Priority Disease. Aug 3, 2015 811
Could this fiber-rich food provide relief for psoriasis and other inflammatory skin diseases? Aug 1, 2015 498
Pop Icon Cyndi Lauper Says "I'm PsO Ready" To Talk about My Life with Psoriasis. Jul 28, 2015 1255
National Psoriasis Foundation, LEO QualityCare and NFL player Jonathan Scott launch Youth Ambassador Program for teens with psoriasis. Jul 25, 2015 846
National Psoriasis Foundation launches patient-centered research platform. Jul 24, 2015 639
National Psoriasis Foundation and Pfizer launch partnership for innovative grants. Jul 15, 2015 732
Phase 2b Findings Published In The New England Journal Of Medicine Demonstrate Significant Efficacy Of Guselkumab In Treatment Of Moderate To Severe Plaque Psoriasis. Jul 8, 2015 2168
Avexxin Completes Phase I/IIA Study in Psoriasis and Achieves Proof-of-Concept in Man With its Compound AVX001 in a Topical Formulation. Jul 2, 2015 694
Avexxin Completes Phase I/IIA Study in Psoriasis and Achieves Proof-of-Concept in Man With its Compound AVX001 in a Topical Formulation. Jul 2, 2015 699
Recognizing guttate psoriasis and initiating appropriate treatment. Vence, Lacey; Schmitt, Amanda; Meadows, Charles E.; Gress, Todd Report Jul 1, 2015 1496
Psoriasis plus depression magnifies MI risk. Jancin, Bruce Jul 1, 2015 431
Dermatological Drugs Market Forecast 2015-2025 Opportunities for Leading Companies. Jun 29, 2015 1847
Dermatological Drugs Market Forecast 2015-2025 Opportunities for Leading Companies. Jun 29, 2015 1851
FOLK THINK THAT I AM CONTAGIOUS. Jun 28, 2015 653
Psoriasis Resource for Healthcare Professionals Launched on epgonline.org. Jun 24, 2015 409
New Drug To Treat Psoriasis. Jun 22, 2015 342
National Psoriasis Foundation awards half a million dollars in fellowships. Jun 22, 2015 999
Naturally Mediterranean Offers Discounted and Free Product to Its Customers in the UK. Jun 13, 2015 332
Lilly Announces Webcast to Discuss Ixekizumab Phase III Data. Jun 11, 2015 567
Novartis presents new data at WCD that shows significant efficacy of Cosentyx in patients with psoriasis of the palms, soles of feet and nails. Jun 11, 2015 2517
New Data Shows LEO Pharma A/S Investigational Psoriasis Treatment, Enstilar, Provides Rapid Itch Relief for Psoriasis Patients. Jun 10, 2015 1280
New Data Shows LEO Pharma A/S Investigational Psoriasis Treatment, Enstilar, Provides Rapid Itch Relief for Psoriasis Patients. Jun 10, 2015 1273
Studies Show Psoriasis Patients Achieved Significant Levels of Skin Clearance and Improved Quality of Life after 12 Weeks of Ixekizumab Treatment. Jun 10, 2015 1960
LEO Pharma Inc. and Professional Football Player Jonathan Scott Partner To Increase Psoriasis Awareness. Jun 8, 2015 620
Asia-Pacific Psoriasis Therapeutics Markets 2015-2021: Advent of Novel Biologics and Expanding Treatment Pool to Drive Growth. Jun 4, 2015 602
Asia-Pacific Psoriasis Therapeutics Markets 2015-2021: Advent of Novel Biologics and Expanding Treatment Pool to Drive Growth. Jun 4, 2015 608
National Psoriasis Foundation awards five Translational Research Grants. Jun 3, 2015 760
National Psoriasis Foundation funds $600,000 in Discovery Grants. Jun 2, 2015 880
National Psoriasis Foundation receives PCORI funding for patient-centered research. Jun 1, 2015 749
Delivery ustekinumabumu in the treatment of severe plaque psoriasis for teaching hospital no. 1 pum.os / zp / 32/15. May 31, 2015 157
Psoriasis 99% gone after a clinical trial. May 22, 2015 490
Delivery ustekinumabumu in the treatment of severe plaque psoriasis for teaching hospital no. 1 pum.os / zp / 32/15. May 16, 2015 155
Rogne Bioscience to Present Data from Topical Biologic Psoriasis Program at Upcoming SID Annual Meeting 2015. May 4, 2015 446
New study finds Pycnogenol[R] effectively treats psoriasis ... and more. Downey, Michael Clinical report May 1, 2015 1540
San Francisco Salt Company Teams Up With the National Psoriasis Foundation for 2015 Events. Apr 22, 2015 822
AnaptysBio Advances First-In-Class Anti-IL-36 Receptor Antibody Program To Treat Orphan Inflammatory Disease. Apr 16, 2015 681
AbbVie's HUMIRA (Adalimumab) Approved by European Commission to Treat Children and Adolescents with Severe Chronic Plaque Psoriasis. Apr 1, 2015 1382
Hospira's INFLECTRA(TM) (Infliximab) Now Available in Canada. Mar 30, 2015 2025
National Psoriasis Foundation backs bill to lower treatment cost. Mar 26, 2015 702
Novartis presents Cosentyx(TM) two-year efficacy and safety data showing sustainable effect in psoriasis patients. Mar 21, 2015 2627
New Novartis data show more Cosentyx(TM)-treated psoriasis patients achieved clear or almost clear skin (PASI 90) compared to Stelara. Mar 20, 2015 2273
Boehringer Ingelheim's Investigational Biologic Cleared Skin Better than Ustekinumab in Head-to-Head Phase II Psoriasis Study. Mar 20, 2015 1171
Creabilis' CT327 Phase 2b Data Published in Acta Dermato-Venereologica, Strengthens Scientific Advisory Board. Mar 19, 2015 1157
Creabilis' CT327 Phase 2b Data Published in Acta Dermato-Venereologica, Strengthens Scientific Advisory Board. Mar 19, 2015 1162
AbbVie's Dermatology Leadership Showcased with HUMIRA (adalimumab) Data at American Academy of Dermatology 2015 Annual Meeting. Mar 17, 2015 2389
AbbVie's Dermatology Leadership Showcased with HUMIRA (adalimumab) Data at American Academy of Dermatology 2015 Annual Meeting. Mar 17, 2015 2414
Amgen To Present 10 Abstracts From Its Dermatology Portfolio At The 73rd Annual Meeting Of The American Academy Of Dermatology. Mar 17, 2015 4640
Naglaa Fathi being treated in Switzerland with newly-invented injections at $52 thousand a pop! Mar 16, 2015 316
Diplomat to Dispense Novartis Psoriasis Drug COSENTYX(TM). Mar 4, 2015 878
AbbVie's HUMIRA (Adalimumab) Receives Positive CHMP Opinion to Treat Children and Adolescents With Severe Chronic Plaque Psoriasis. Feb 27, 2015 1242
First independent U.S. psoriasis registry will track drug safety and effectiveness. Feb 26, 2015 761
Can-Fite Receives Notice of Allowance in U.S. for Psoriasis Patent. Feb 17, 2015 1188
Free nationwide event educates Americans about triggers, treatments for most common autoimmune disease. Feb 17, 2015 498
Corticosteroid spray relieved psoriasis scaling. Worcester, Sharon Feb 15, 2015 355
Cipher Pharmaceuticals Announces Beteflam Patch Accepted For Review By Health Canada. Feb 12, 2015 1014
THE story on our website [...]; @dailyrecord. Feb 9, 2015 167
Someone said my skin was offensive so they wanted me out of the store. I have never felt so humiliated; PSORIASIS SUFFERER'S SHOP ORDEAL; Customer rages but managers insist she is welcome. Feb 8, 2015 708
Can-Fite Completes Phase II/III Trial for CF101 in Treatment of Psoriasis. Feb 4, 2015 1219
Global Dermatology Devices (Cancer Diagnosis, Acne, Psoriasis, Hair Removal) Market - Forecast to 2019. Feb 3, 2015 608
Global Dermatology Devices (Cancer Diagnosis, Acne, Psoriasis, Hair Removal) Market - Forecast to 2019. Feb 3, 2015 635
Dermatology Devices Market by Diagnostic Devices (Dermatoscope, Microscope, Imaging Techniques), Treatment Devices (Liposuction, Microdermabrasion, Lasers) & by Application (Cancer Diagnosis, Acne, Psoriasis, Hair Removal) - Global Forecast to 2019. Feb 2, 2015 635
Arthritis mutilans: a rare phenomenon. Madua, M.C. Clinical report Feb 1, 2015 683
Switzerland : Novartis announces FDA approval for first IL-17A antagonist Cosentyx(TM) (secukinumab) for moderate-to-severe plaque psoriasis patients. Jan 22, 2015 435
United States : FDA approves new psoriasis drug Cosentyx. Jan 22, 2015 456
Novartis announces FDA approval for first IL-17A antagonist Cosentyx(TM) (secukinumab) for moderate-to-severe plaque psoriasis patients. Jan 21, 2015 2584
Switzerland : Novartis Cosentyx(TM) is the first IL-17 inhibitor to receive EU approval for first-line treatment of moderate-to-severe psoriasis patients. Jan 20, 2015 418
Global Psoriasis Therapeutics Market 2015-2019. Jan 7, 2015 844
Denmark : LEO Pharma announces US regulatory submission of the first aerosol foam for psoriasis. Jan 6, 2015 227
LEO Pharma Announces US Regulatory Submission of the First Aerosol Foam for Psoriasis. Jan 6, 2015 921
Can-Fite Announces Upcoming 2015 Clinical Milestones for its Pipeline of Drugs in 4 Indications. Jan 6, 2015 1195
LEO Pharma Announces New Drug Application Submission of the First Aerosol Foam for Plaque Psoriasis. Jan 5, 2015 688
Switzerland : Head-to-head psoriasis study demonstrates superiority of Novartis Cosentyx(TM) to Stelara in clearing skin. Dec 13, 2014 378
From the publisher. Collin, Jonathan Nov 29, 2014 1776
Not skin deep: Psoriatic arthritis and the complications of systemic inflammation seen with psoriasis. Wood, Sara Nov 29, 2014 4096
Las Vegas Dermatology and Vegas Magazine Partnered for a Night of Beauty Benefiting the National Psoriasis Foundation. Nov 25, 2014 472
Switzerland : Novartis Cosentyx(TM) receives positive CHMP opinion for first-line treatment of moderate-to-severe psoriasis patients. Disease/Disorder overview Nov 22, 2014 436
Can-Fite Near-Term Milestones Timetable for 2014/2015. Nov 18, 2014 1034
Al-Adan Hospital treats over 40,000 patients monthly. Nov 14, 2014 327
Psoriasis - Pipeline Review, H2 2014. Nov 12, 2014 700
In The Psoriasis Drug Market, Continued Uptake of Janssen's Stelara and the Launch of Emerging Systemic Therapies Will Drive Sales Growth to $10.7 Billion in 2023. Nov 5, 2014 645
National Psoriasis Foundation launches Team NPF Cycle program on World Psoriasis Day. Oct 29, 2014 518
Switzerland : Novartis announces FDA Advisory Committee unanimously recommends approval of AIN457 (secukinumab) for patients with moderate-to-severe plaque psoriasis. Oct 21, 2014 437
Novartis announces FDA Advisory Committee unanimously recommends approval of AIN457 (secukinumab) for patients with moderate-to-severe plaque psoriasis. Oct 20, 2014 1722
Living with psoriasis TREATMENTS; Agony of thousands who suffer pain and a loss of confidence from skin condition. Oct 15, 2014 708
Janssen Submits Application Seeking Approval Of STELARA In European Union For Pediatric Plaque Psoriasis. Oct 10, 2014 2044
New Findings From The Psoriasis Longitudinal Assessment And Registry (PSOLAR) Show Persistency Difference Among Biologic Therapies(1). Oct 9, 2014 1048
PsoriaTrax Coal Tar Shampoo AVAILABLE: New shampoo finds a solid niche for people suffering from psoriasis. Oct 9, 2014 230
Medac Pharma, Inc.'s Rasuvo (methotrexate) injection Now Available for Patients With Rheumatoid Arthritis, Poly-Articular-Course Juvenile Idiopathic Arthritis and Psoriasis. Oct 6, 2014 2191
American Journal of Medicine to publish International Psoriasis Council article outlining evidence how psoriasis may be linked to cardiometabolic diseases. Oct 6, 2014 591
American Journal of Medicine to publish International Psoriasis Council article outlining evidence how psoriasis may be linked to cardiometabolic diseases. Oct 6, 2014 598
Words of hope. Oct 5, 2014 275
Otezla (apremilast) receives expanded indication; Diplomat to distribute. Oct 1, 2014 564
Amgen Announces Moderate-To-Severe Plaque Psoriasis Data To Be Presented At The 23rd Congress Of The European Academy Of Dermatology And Venereology. Oct 1, 2014 3943
Chronic inflammatory disease raises cardiovascular risk. Sep 22, 2014 210
Can Fite's Drug CF101 is Presented in Scientific Journal as One of Four Small Molecule Drugs for the Treatment of Psoriasis. Sep 17, 2014 923
Boswellia cream may help treat psoriasis. Sep 1, 2014 273
Boswellia cream may help treat psoriasis. Sep 1, 2014 273
Rheumatic diseases and pregnancy. Gcelu, A. Report Sep 1, 2014 3675
Lilly's Ixekizumab Superior to Etanercept and Placebo in Phase 3 Psoriasis Studies. Aug 21, 2014 1492
Kim Kardashian's Battle With Psoriasis, How to Fight It. Aug 11, 2014 374
Two genes clear up confusion over psoriasis and eczema. Akpan, Nsikan Brief article Aug 9, 2014 140
New Data Shows High Efficacy for Can-Fite's CF101 in Rheumatoid Arthritis and Psoriasis Patients. Aug 6, 2014 904
Systemic Psoriasis Therapeutics in Major Developed Markets to 2020 - Continued Uptake of Biologics and Novel Pipeline Drugs to Drive Growth. Aug 5, 2014 2022
Surveyed U.S. and EU5 Dermatologists Indicate that Short-Term and Long-Term Effects on Psoriatic Plaque Clearance are Two Attributes that Most Strongly Influence Prescribing Decisions in Moderate to Severe Psoriasis. Jul 24, 2014 652
Vital to review medication. Jul 23, 2014 190
my own body A prisoner in; It's a common skin condition that affects 1.8 million people, yet the true devastating effects of psoriasis are little known. Sufferer Ranjit Kaur tells Health Correspondent ANUJI VARMA how the disease has ruined her life. Jul 23, 2014 1051
United States : Three UCSF Scientists Receive Funding for Psoriasis Research. Jul 23, 2014 352
National Psoriasis Foundation awards 13 psoriasis research fellowships. Jul 17, 2014 846
Coherus Announces Initiation Of Phase 3 Trial Of CHS-0214 (Investigational Etanercept Biosimilar) In Chronic Plaque Psoriasis (RaPsOdy). Jul 16, 2014 847
Coherus Announces Initiation Of Phase 3 Trial Of CHS-0214 (Investigational Etanercept Biosimilar) In Chronic Plaque Psoriasis (RaPsOdy). Jul 16, 2014 851
National Psoriasis Foundation awards more than $1 million in psoriatic disease research grants. Jul 16, 2014 1003
Medac Pharma, Inc. Secures FDA Approval of Rasuvo (methotrexate) injection for Rheumatoid Arthritis, Poly-Articular-Course Juvenile Idiopathic Arthritis and Psoriasis. Jul 14, 2014 2340
Frontier Pharma: Psoriasis - Identifying and Commercializing First-in-Class Innovation. Jul 10, 2014 1725
Switzerland : Novartis announces NEJM publication of two phase III studies demonstrating high efficacy of secukinumab (AIN457) in psoriasis patients. Jul 10, 2014 126
National Psoriasis Foundation launches new five-year strategic plan and mission. Jul 9, 2014 585
Psoriasis Treatment Pipeline Shows High Level of Innovation in First-in-class Molecules. Jul 9, 2014 794
Frontier Pharma: Psoriasis - Identifying and Commercializing First-in-Class Innovation. Jul 9, 2014 425
Psoriasis Treatment Pipeline Shows High Level of Innovation in First-in-class Molecules. Jul 9, 2014 788
Frontier Pharma: Psoriasis - Identifying and Commercializing First-in-Class Innovation. Jul 9, 2014 431
Novartis announces NEJM publication of two pivotal Phase III secukinumab studies demonstrating statistically significant skin clearance in psoriasis patients. Jul 9, 2014 2692
Epigenetics and genetics: are our ancestors to blame for susceptibility to modern disease? Meletis, Chris D.; Wilkes, Kimberly Report Jul 1, 2014 3999
Women's health update: skin aging, psoriasis, and radiation dermatitis. Hudson, Tori Jul 1, 2014 1441
Quest Products, Inc. Introduces New ProVent Eczema and Psoriasis Spray. Jun 25, 2014 529
Medicinal products for dermatology. Jun 21, 2014 365
Ireland leading the way. Jun 19, 2014 502
Efficacy and safety of indigo naturalis extract in oil (Lindioil) in treating nail psoriasis: a randomized, observer-blind, vehicle-controlled trial. Lin, Yin-Ku; See, Lai-Chu; Huang, Yu-Huei; Chang, Ya-Ching; Tsou, Teng-Cheng; Lin, Tung-Yi; Lin, Na- Report Jun 15, 2014 4669
Under the skin of psoriasis; Vital health. Jun 4, 2014 303
Psoriasis Treatment: World Drug Market 2013-2023. Jun 3, 2014 4570
The World Health Assembly Resolution on Psoriasis Represents a Milestone for Campaigners. Research-based Pharmaceutical Industry Adds its Voice by Calling for Greater Focus on Awareness, Research and Access. May 9, 2014 431
The World Health Assembly Resolution on Psoriasis Represents a Milestone for Campaigners. Research-based Pharmaceutical Industry Adds its Voice by Calling for Greater Focus on Awareness, Research and Access. May 9, 2014 441
Covagen Initiates Phase Ib/IIa Study of Bispecific anti-TNF/IL-17A FynomAb COVA322. May 5, 2014 689
While Use of Biologics in the Treatment of Psoriasis is Stagnating in the Major European Markets, Stelara Continues to Lure Dermatologists. May 5, 2014 515
Study Finds Natural Extract Pycnogenol To Improve Psoriasis Symptoms Including Redness, Skin Hardening And Flaking. May 1, 2014 1135
Emerging Psoriasis Therapies go Head-to-Head with Marketed Drugs to Win Over Physicians, Patients and Payors. Apr 30, 2014 1147
Emerging Psoriasis Therapies go Head-to-Head with Marketed Drugs to Win Over Physicians, Patients and Payors. Apr 30, 2014 1145
Systemic Psoriasis Therapeutics in Major Developed Markets to 2020 - Continued Uptake of Biologics and Novel Pipeline Drugs to Drive Growth. Apr 28, 2014 1908
The conclusion of a framework agreement for the supply of the drug for the treatment of psoriasis bio - humiry the needs of the specialist hospital in zabrze. ref. dzp/17pn/2014 case. Apr 25, 2014 133
Ask Dr Miriam. Apr 11, 2014 161
Ask Dr Miriam. Apr 11, 2014 164
Global Psoriasis Therapeutics Market. Apr 9, 2014 745
Global Psoriasis Therapeutics Market. Apr 9, 2014 739
United States : PERRIGO intros generic TACLONEX ointment to deal with plaque psoriasis. Apr 5, 2014 189
HLA-B27 real-time PCR using TaqMan-MGB sequence specific probes. Smith, Stewart M.; Laurie, Andrew D.; Potter, Howard C.; McGettigan, Ben D. Report Apr 1, 2014 3591
Therapeutic Class Overview: Psoriasis - Plaque Psoriasis & Psoriatic Arthritis - Novel Oral Drugs And Biologics To Change Future Treatment Paradigm. Mar 27, 2014 424
Can-Fite to Present at the 9th International Congress of Autoimmunity. Mar 25, 2014 1086
Anti-Interleukin-23 Monoclonal Antibody Guselkumab Shows Significant Efficacy in Treatment Of Moderate To Severe Plaque Psoriasis. Mar 24, 2014 1932
Novartis reports new Phase III data showing secukinumab (AIN457) improved moderate-to-severe plaque psoriasis in patients. Mar 22, 2014 2579
AbbVie Initiates New Clinical Trial to Evaluate HUMIRA (adalimumab) for the Treatment of Fingernail Psoriasis in Patients with Moderate to Severe Chronic Plaque Psoriasis. Mar 20, 2014 1835
AbbVie Initiates New Clinical Trial to Evaluate HUMIRA (adalimumab) for the Treatment of Fingernail Psoriasis in Patients with Moderate to Severe Chronic Plaque Psoriasis. Mar 20, 2014 1831
Oral molecules being tested as topicals for psoriasis. Smith, Jennie Mar 15, 2014 301
Calcipotrience/betamethasone for psoriasis cut costs. Jancin, Bruce Mar 1, 2014 360
Incurable 'Flesh-Eating' Disease in Pangasinan is a Hoax: Just Cases of Leprosy and Psoriasis, Says Philippines Health Department. Feb 25, 2014 394
United States : PhotoMedex expands business with LCA-Vision acquisition for over $106 MILLION. Feb 20, 2014 227
Health details of care home worker were 'pinned up'. Feb 19, 2014 206
Can-Fite Provides Update on Key Milestones for 2014. Feb 18, 2014 1089
Depression accounts for psoriatics' increased MI risk. Jancin, Bruce Feb 1, 2014 244
I was teased at school, dumped by a boyfriend and abused at work for having a skin condition; Leigh tells how she suffered psoriasis for 20 years until she discovered the cream that finally conquered it and restored her self-confidence. Jan 23, 2014 1255
Can-Fite to Present New Clinical Data from Further Analysis of its Clinical Studies of CF101 for the Treatment of Rheumatoid Arthritis and Psoriasis at OneMedForum and Biotech Showcase held in San Francisco, California. Jan 13, 2014 902
The helping hand. Jan 11, 2014 1149
First nonprofit psoriasis registry may improve treatments and outcomes for nation's most common autoimmune disease. Jan 8, 2014 711
Ask Dr Miriam. Jan 3, 2014 154
Germany : Sandoz begins Phase III clinical trial for biosimilar adalimumab. Company overview Dec 20, 2013 411
Don't brush off topical therapies for psoriasis. Splete, Heidi Dec 1, 2013 410
doctor doctor. Nov 29, 2013 300
doctor. Nov 27, 2013 300
doctor. Nov 27, 2013 299
doctor. Nov 26, 2013 300
doctor. Nov 26, 2013 300
doctor. Nov 26, 2013 300
THE DOCTOR; Neil is here to answer all your health queries. Write to him at Dr Neil, Sunday Mail, One Central Quay, Glasgow G3 8DA. Nov 24, 2013 298
PhotoMedex Ranked Number 143 Fastest Growing Company in North America on Deloitte's 2013 Technology Fast 500(TM). Nov 13, 2013 875
Psoriasis Treatment: World Drug Market 2013-2023. Nov 5, 2013 4608
Survey Shows Psoriasis Care Falling Short of Recommended Clinical Guidelines. Nov 4, 2013 1543
Psoriasis left me crippled. Nov 1, 2013 672
3 of the best soothing psoriasis solutions. Oct 30, 2013 181
3 of the best soothing psoriasis solutions. Oct 29, 2013 181
Lectures on skin disease, sleeplessness. Oct 29, 2013 244
Campaign launched on World Psoriasis Day. Oct 29, 2013 405
'Stop Hiding, Take Action!' - European Psoriasis Film Campaign Launched to Mark World Psoriasis Day. Oct 28, 2013 825
What's the difference? ECZEMA & PSORIASIS. Oct 25, 2013 113
What's the difference? ECZEMA & PSORIASIS. Oct 25, 2013 122
What's the difference? ECZEMA & PSORIASIS. Oct 25, 2013 114
UCB-sponsored Data on Cimzia (certolizumab pegol) to be Highlighted at 2013 American College of Rheumatology Annual Scientific Meeting. Oct 25, 2013 3985
Condition really gets under your skin; HEALTH. Oct 25, 2013 1267
Condition really gets under your skin. Oct 23, 2013 1221
Condition really gets under your skin; Psoriasis can affect anyone - even top fashion models like Cara Delevingne, who has hinted that she may quit the catwalk due flare ups. As Psoriasis Awareness Week approaches, ABI JACKSON reveals just how distressing this chronic skin problem can be for some. Oct 23, 2013 1223
Condition reallygets under your skin; Psoriasis can affect anyone - even top fashion models like Cara Delevingne, who has hinted that she may quit the catwalk due flare ups. As Psoriasis Awareness Week approaches, ABI JACKSON reveals just how distressing this chronic skin problem can be for some. Oct 22, 2013 1223
Condition really gets under your skin. Oct 22, 2013 1233
Condition really gets under your skin; Psoriasis can affect anyone - even top fashion models like Cara Delevingne, who has hinted that she may quit the catwalk due flare ups. As Psoriasis Awareness Week approaches, ABI JACKSON reveals just how distressing this chronic skin problem can be for some. Oct 22, 2013 1227
In the Psoriasis Drug Market, Continued Uptake of Janssen's Stelara and the Launch of Emerging Systemic Therapies Will Drive Sales Growth to Nearly $9.2 Billion in 2022. Oct 21, 2013 708
Galderma Serves as Premier Sponsor for 2013 Commit to Cure Gala Benefitting National Psoriasis Foundation. Oct 18, 2013 880
Psoriasis linked to nonalcoholic fatty liver disease. Jancin, Bruce Oct 15, 2013 697
Malaysia : Guideline for the treatment and management of Psoriasis Vulgaris released by Health Ministry. Oct 15, 2013 148
Amgen And AstraZeneca Highlight Data To Be Presented At 22nd Congress Of The European Academy Of Dermatology And Venereology. Oct 3, 2013 1693
Protective effect of ethyl pyruvate on epididymal sperm characteristics, oxidative stress and testosterone level in methotrexate treated mice. Atashfaraz, Elham; Farokhi, Farah; Najafi, Gholamreza Oct 1, 2013 4018
Moleculin Reports Positive Data From Controlled Study of Novel Topical Psoriasis Treatment. Clinical report Sep 30, 2013 592
Skin drug may hold key to type 1 diabetes treatment. Sep 23, 2013 197
Calling readers with psoriasis; FEEDBACK. Sep 13, 2013 159
Hospira's Inflectra(TM) (infliximab) the first biosimilar monoclonal antibody to be approved in Europe. Sep 10, 2013 2321
Hospira's Inflectra(TM) (infliximab) the first biosimilar monoclonal antibody to be approved in Europe. Sep 10, 2013 2323
For psoriasis patients, depression is top comorbidity. Jancin, Bruce Sep 1, 2013 307
The relationship of osteopontin and related cytokin levels with disease activity, treatment and comorbidities in psoriasis vulgaris/Psoriasis vulgariste osteopontin ve iliskili sitokin duzeylerinin tedavi, hastalik aktivitesi ve komorbiditeler ile iliskisi. Bulur, Isil; Gulekon, Ayla; Erdem, Ozlem; Yucel, Aysegul Atak; Celik, Sevinc; Aral, Arzu Report Sep 1, 2013 4537
Run in aid of skin charity. Aug 30, 2013 157
Psoriasis treatments 2012-2013 Patent Landscape. Aug 22, 2013 1247
Psoriasis is major itch for millions; Vital health Chronic skin condition affects all ages and branches of society - from teenagers to supermodels. But it can be controlled. Aug 20, 2013 458
Sunshine and relaxation will help Cara's psoriasis; MODEL CARA DELEVINGNE MAY QUIT THE CATWALK OVER HER SKIN CONDITION - BUT THERE IS HOPE, SAY FELLOW SUFFERERS. Aug 15, 2013 1043
Sunshine and relaxation will help Cara's psoriasis; MODEL CARA DELEVINGNE MAY QUIT THE CATWALK OVER HER SKIN CONDITION - BUT THERE IS HOPE, SAY FELLOW SUFFERERS. Aug 15, 2013 1100
Psoriasis - Current and Future Players. Aug 15, 2013 975
Cara Delevingne on W Magazine: Victoria's Secret Model Poses Topless. Aug 13, 2013 325
Summer sun 'natural medication' for psoriasis sufferers. Aug 12, 2013 184
PharmaPoint: Psoriasis - India Drug Forecast and Market Analysis to 2022. Industry overview Jul 23, 2013 1335
PharmaPoint: Psoriasis - China Drug Forecast and Market Analysis to 2022. Industry overview Jul 23, 2013 1365
PharmaPoint: Psoriasis - US Drug Forecast and Market Analysis to 2022. Industry overview Jul 23, 2013 1633

Terms of use | Copyright © 2016 Farlex, Inc. | Feedback | For webmasters